{
  "doc_id": "Gastritis-Chronic-Erosive",
  "doc_filename": "Gastritis-Chronic-Erosive.pdf",
  "top_entities": [
    {
      "name": "erosive gastritis",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "Crohn's disease",
      "mention_count": 1,
      "entity_type": "disease"
    },
    {
      "name": "Aspirin",
      "mention_count": 1,
      "entity_type": "drug"
    },
    {
      "name": "Ibuprofen",
      "mention_count": 1,
      "entity_type": "drug"
    }
  ],
  "file_size_bytes": 2303,
  "file_size_human": "2.2 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:17",
  "doi": null,
  "doi_url": null,
  "document_type_code": "MED",
  "document_type_name": "Patient Education & Advocacy",
  "document_type_group": "Patient-Centric Documentation",
  "classification_confidence": 0.15,
  "title": "Chronic, Erosive Gastritis: Clinical Overview and Patient Information",
  "short_description": "Clinical document describing chronic, erosive gastritis, its symptoms, causes, and diagnostic approaches.",
  "long_description": "This clinical reference document provides a comprehensive overview of chronic, erosive gastritis, a condition characterized by multiple inflamed lesions in the stomach's mucous lining. The document covers the pathophysiology, clinical presentation including symptoms such as stomach burning, nausea, and potential bleeding complications, diagnostic methods using gastroscopy, and various etiological factors including alcohol use, NSAID medications, and underlying conditions like Crohn's disease. It also addresses patient demographics, risk factors, and the potential for asymptomatic presentation in certain patient populations, particularly chronic aspirin users.",
  "document_date": "2026-01-07T22:25:17",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T04:46:05.869239"
}